Authors hope findings will ‘inform a more cautious approach to decisions around opioid dose tapering’
WEDNESDAY, June 29, 2022 (HealthDay News) — Opioid tapering is associated with increased rates of overdose, withdrawal, and mental health crisis extending up to two years after taper initiation, according to a study published online June 13 in JAMA Network Open.
Joshua J. Fenton, M.D., M.P.H., from the University of California Davis in Sacramento, and colleagues assessed whether opioid dose tapering is associated with reduced longer-term risks of overdose, withdrawal, or mental health crisis in patients prescribed long-term opioids. Analysis included 19,377 U.S. adults who underwent opioid dose tapering from 2008 to 2017 after a 12-month baseline period of stable daily dosing.
The researchers found that adjusted incidence rate ratios for the postinduction period versus the pretaper period were 1.57 for overdose or withdrawal and 1.52 for mental health crisis.
“We hope this work will inform a more cautious approach to decisions around opioid dose tapering,” Fenton said in a statement. “While our results suggest that all tapering patients may benefit from monitoring and support up to two years after taper initiation, patients prescribed higher doses may benefit from more intensive support and monitoring, particularly for depression and suicidality.”
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users 
CDC: Buprenorphine Treatment Differs in Urban, Rural Areas 
Mindfulness, Tai Chi May Benefit Cancer Survivors 
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage .jpeg)
Breathing Interventions May Curb Cravings With Substance Use 
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients 
